Do you want to read an article? Please log in or register.
Usefulness of a Simple Algorithm to Identify Hypertensive Patients Who Benefit from Intensive Blood Pressure Lowering
Cardiovascular Risk and DiseasesHypertension
Related content
Cardiovascular Risk and DiseasesHypertension
Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients with Hypertension: The Systolic Blood Pressure Intervention (SPRINT) Trial
Circulation.
Soliman EZ, Ambrosius WT, Cushman WC, Zhang ZM, Bates JT, Neyra JA, Carson TY, Tamariz L, Ghazi L, Cho ME, Shapiro BP, He J, Fine LJ, Lewis CE; SPRINT Research Study Group
doi: 10.1161/
Cardiovascular Risk and DiseasesHypertension
Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis
JAMA Intern Med.
Malhotra R, Nguyen HA, Benavente O, Mete M, Howard BV, Mant J, Odden MC, Peralta CA, Cheung AK, Nadkarni GN, Coleman RL, Holman RR, Zanchetti A, Peters R, Beckett N, Staessen JA, Ix JH
doi: 10.1001/
RECOMMENDED
HypertensionLipid-Lowering DrugsThrombosis and Stroke
Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial
Lancet.
Gupta A, Mackay J, Whitehouse A, Godec T, Collier T, Pocock S, Poulter N, Sever P
doi: 10.1016/S0140-
Cardiovascular Risk and DiseasesHypertension
Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes
N Engl J Med.
Berlowitz DR, Foy CG, Kazis LE, Bolin LP, Conroy MB, Fitzpatrick P, Gure TR, Kimmel PL, Kirchner K, Morisky DE, Newman J, Olney C, Oparil S, Pajewski NM, Powell J, Ramsey T, Simmons DL, Snyder J, Supiano MA, Weiner DE, Whittle J; SPRINT Research Group
doi: 10.1056/NEJMoa1611179.
Cardiovascular Risk and Diseases
Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial)
Hypertension.
Khan NA, Rabkin SW, Zhao Y, McAlister FA, Park JE, Guan M, Chan S, Humphries KH
doi: 10.1161/
Hypertension
Comparing Automated Office Blood Pressure Readings With Other Methods of Blood Pressure Measurement for Identifying Patients With Possible Hypertension: A Systematic Review and Meta-analysis
JAMA Intern Med.
Roerecke M, Kaczorowski J, Myers MG
doi: 10.1001/jamainternmed.
Cardiovascular Risk and DiseasesHypertension
Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control
N Engl J Med.
Bress AP, Bellows BK, King JB, Hess R, Beddhu S, Zhang Z, Berlowitz DR, Conroy MB, Fine L, Oparil S, Morisky DE, Kazis LE, Ruiz-Negrón N, Powell J, Tamariz L, Whittle J, Wright JT Jr, Supiano MA, Cheung AK, Weintraub WS, Moran AE; SPRINT Research Group
doi: 10.1056/NEJMsa1616035.
COMMENTED
Hypertension
Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)
★ 3
Recommended and commented by
Prof. Dr Isabella Sudano, Faculty Member
JAMA Cardiol.
Vaduganathan M, Claggett BL, Juraschek SP, Solomon SD
doi: 10.1001/jamacardio.2019.6192.
Hypertension
Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians
Ann Intern Med.
Qaseem A, Wilt TJ, Rich R, Humphrey LL, Frost J, Forciea MA; Clinical Guidelines Committee of the American College of Physicians and the Commission on Health of the Public and Science of the American Academy of Family Physicians
doi: 10.7326/M16-1785.